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 Valorisation 
The social and economic relevance of the research results 
The main focus of the thesis are most commonly diagnosed worldwide bacterial and viral 
sexually transmitted infections (STI), namely Chlamydia trachomatis (Ct) and human 
papillomavirus (HPV). Among long term complications of Ct are pelvic inflammatory 
disease, ectopic pregnancy, infertility, and ocular and respiratory infections in newborns. 
Persistent infection with HPV is a necessary cause of most of cervical and anal cancers, 
some cancers of the vagina, vulva, penis, rectum, oropharynx, head and neck, as well as 
skin and genital warts. In addition, both infections can facilitate HIV transmission. 
Although the two STIs are major health problems, causing serious morbidity and 
mortality, estimates of the global prevalence and incidence of both Chlamydia and HPV 
infections are limited by quantity and quality of data available from the different regions 
of the world due to the nature of the pathogens or the lack of reliable information from 
many world areas, as a result of the variety of surveillance systems or approaching high-
risk populations (i.e., the presence of stigma). This also applies to such country as the 
Russian Federation, which originally centralized around clinical dermatovenereology 
services model of STI control faced tremendous challenges during the last decades caused 
by an abrupt free-market transition in the 1990’s followed by socio-political and 
economic changes that contributed to rocketing of the burden of STI, including HIV. In 
addition, the scarce funding for health care and its management resulted in limited 
research studies on STIs in the country.  
     Addressing the burden of STIs is important in efforts to achieve the health ambitions of 
the Sustainable Development Goals, as embodied in the global health sector strategy on 
STI 2016-2021 which was adopted by the 69th World Health Assembly of the World 
Health Organization in May 2016. 
     This work starts with the stocktake of all available data on the prevalence of genital Ct 
infections in all available peer reviewed studies for Russian populations. This analysis was 
additionally expanded with data from the multicenter study run in the second-largest 
Russian city of St. Petersburg among 1263 people whose urethral, anal, cervical, and 
prostate samples were tested for the presence of Ct DNA in St. Petersburg and in 
Amsterdam. The study (Chapter 2) revealed that the overall prevalence of genital Ct 
infections across different Russian populations may range from 2.9% to 33%. The 
 multicenter study specified the risk factors, which included being symptomatic (observed 
in particular among men), being younger than 30 years, and being a man who has sex with 
men (MSM). The initiation of screening programmes for Ct infections applied to high-risk 
populations (i.e., young people, women and men with multiple partners, MSM, 
commercial sex workers, drug users) in Russia was suggested to be considered. As Ct 
detection with Russian tests in some settings in St. Petersburg yielded levels of reliability 
comparable with internationally available tests, such screening programmes could rely 
on less costly locally manufactured tests, though if quality of sampling and testing will 
remain sustainable only. Currently, testing for Ct in Russia is obligated among some 
population groups such as pregnant women, gynaecological or venerological patients and 
men with urogenital symptoms. The deployment of screening programmes for Ct targeting 
high-risk group populations would bring additional benefits to the Russian health care 
system and patients. This will result in earlier detection and treatment of Ct, reduction in 
transmission of other STI, including HIV, and, also, decrease in Chlamydia-related long 
term complications across the nation. It will further help in evaluation the real incidence 
of STI, antibiotic resistance, and molecular epidemiology. All of these would result in 
reducing the costs for the country’s health care system. 
     The observed geographic variations in Chlamydia serovar (Chapter 3) and strain types 
(Chapter 4) distribution between Russia and other geographic regions, due to potential 
selective mixing and adaptive diversification, supports further studies that employ 
extended numbers of isolates among cohorts with different risk profiles for infections and 
with the spread of different variants of Chlamydia. This approach could result in 
establishment of biobanks of Ct/STI samples. Such studies will be of great value as they 
could help to explain differences in Ct and STI prevalence at a population level and could 
provide useful insight into microbiological characteristics of infection (e.g. concurrence 
of infection, bacterial load, and resistance patterns), molecular epidemiology and 
transmission which all are essential for developing prevention strategies, especially given 
the increasing globally number of cross-border trips, migration and expanding 
international sexual networks. 
     Importantly, current medical practice worldwide does not always facilitate discussion 
of sexual behaviours and MSM may face different barriers that do not experience many of 
heterosexual men. Among them, but not limited to, are the lack of welcoming clinical 
environment and adequate health insurance (e.g., no health insurance through the 
 spouse's employer as same-sex marriage currently is not an option in many countries). 
Conducting a study presented in Chapter 5, on evaluation of the microbial cure of 
Chlamydia LGV and non-LGV with doxycycline treatment by testing for Ct DNA and RNA 
persistence in Dutch MSM anal swab specimens, is difficult or even impossible in 
countries where MSM are less visible, as a result of the social stigma or religious laws that 
strictly prohibit homosexuality. A joint approach with political, including social and 
economic, commitment to reduce stigma is of great relevance. From a public health 
perspective, stigma is important because it contributes to delays in seeking treatment, 
and, therefore, increased risk of STI transmission. The lack of stigma will help to better 
identify risk factors and detect an infectious agent. Conducting such a study in the 
Netherlands allowed properly to identify the risk factors (MSM and HIV-positivity), detect 
an infectious agent (Ct LGV vs non-LGV strains) and result in the support to develop 
international recommendations on extended treatment regimen for LGV (21-days) versus 
non-LGV (7-day) Ct proctitis.  
     Studies of the epidemiology of HPV infection in men are essential. Understanding HPV 
natural history and transmission dynamics will lead towards improvements in cancer 
control through optimal uses of HPV vaccines in both women and men. The thesis broadens 
knowledge on the natural history of mucosal and cutaneous HPV infections and evaluates 
epidemiological and diagnostic aspects of oncogenic and cutaneous HPVs in men in 
particular.  
     Expressed prostate secretion (EPS) samples represent additional informative and 
relatively easy to obtain sampling material for the studies on urogenital infections. 
Interestingly, Chlamydia prevalence was found higher in the groups where urethral 
samples were pooled with EPS samples (Chapter 2). Combining urethral and EPS samples 
resulted in the 42.0% high-risk HPV-positivity in the studied population the majority of 
which was represented by HIV-negative men who have sex with women (MSW) (Chapter 
6), almost twice as much as seen when analysing only samples from the distal urethra. 
EPS tested alone or in a combination with urethral swabs might not provide the complete 
picture but undoubtedly improve our understanding of abundance of genital microbiota. 
Obtained findings support further studies to elucidate whether the shift in microbiome 
(prostate or genital) could be involved in cancerogenesis, i.e. by applying the samples 
obtained in men preceding the diagnosis of urogenital (prostate) and anal cancers. 
Contrary to the prostate tissue that requires performing the prostate biopsy, EPS is 
 relatively easy (and not-expensive) to obtain at the time of routine urological 
examination. In addition, because of the presence of EPS in the ejaculate, the study of EPS 
is of particular interest in studies of the transmission of infections to the sexual partner(s).  
     The data on HPV prevalence in heterosexual males worldwide are scarce. The thesis 
broadens knowledge on the prevalence and the determinants of presence for a broad 
range of cutaneous β, γ (Chapter 7) and mucosal α (Chapter 8) HPV types in the anal 
canal of men, in which MSM and MSW were recruited from the same population, using a 
Luminex technology. Knowledge on HPV epidemiology obtained in diverse male populations 
is essential for a better understanding of transmission to sexual partners and the role of 
different HPVs as co-factors in the anogenital carcinogenesis. Sexual orientation and HIV 
status were major determinants of anal presence for all three HPV genera but anal 
cutaneous and mucosal HPVs were commonly found among the studied Russian 
heterosexual men (24%, 14% and 15.7% for β-, γ- and α-HPVs, respectively). The routes 
for the transmission of HPVs into the anal canal in MSW remain unclear. Although the 
presence of HPV DNA may not necessarily indicate presence of infectious virus, the 
obtained findings posit that routes other than penile-anal intercourse may be important 
in HPV transmission. Also, the studied MSW population does not represent the general 
population but HPV is known to be associated with a variety of cancers in men, including 
anal cancer and a subset a subset of penile and oral cancer, which incidence has been 
increasing during the last decades. The gender-neutral HPV routine vaccination could be 
recommended to be introduced as a part of cancer prevention strategy. Such vaccination 
may prevent genital warts and the spread of HPV to sexual partners through the herd 
immunity.  
     The international cooperation and knowledge transfer is of great importance for public 
health worldwide. During the last few decades much progress has been made in the 
management of several STIs, including Chlamydia and HPV infections, globally. The thesis 
provides an insight that such progress would be impossible without the knowledge 
transfer provided by the leading state-of-art centres located mostly in high-income 
countries to low- and middle-income countries (LMICs), which results in the development 
and spread of technically advanced facilities in LMICs and save many human lives across 
the globe.  
 
 
 Target groups 
This work contains useful information and specific recommendations for the evaluation 
of the current STI control strategies with a focus on low-resource settings. In addition to 
new scientific knowledge such as the first overview of data on the prevalence of Ct in 
Russia, first data on Ct serotypes, serogroups and strains in Russia, evidence for the 
microbiological cure of Ct LGV and non-LGV proctitis, first data on the role of prostate 
secretion in the studies on HPV epidemiology in men, first data on the distribution of anal 
cutaneous β- and γ-HPVs and data on prevalence and the determinants of the presence 
for mucosal and cutaneous HPVs in the anal canal in HIV-negative heterosexual men (with 
a potential role of auto-inoculation), this thesis provides essential information for 
healthcare in general and for society, both in Russia and worldwide. The ongoing 
transmission of Ct, HPV and other STI, including HIV transmission as a result of high risk 
behaviour and the weakness of existing STI control, and low performance of cancer 
prevention and control management, including the lack of organized cervical cancer 
screening and HPV vaccination programmes is a challenge which need individual, 
national, and global attention and commitment. 
 
Population of reproductive age 
First, the results of this thesis are of importance for the whole sexual active population in 
Russia and in other low- and middle-income resource settings. Individuals of reproductive 
age should be aware of the common occurrence of genital and anal infections, their long 
term complications, and potential role in HIV transmission. Moreover, they should be aware 
of common high risk behaviour as described in the current thesis. 
 
National policy makers 
Second, policy makers on the federal (Ministry of Health) and regional (republican, 
provincial and territorial ministries of health) levels are a target. The advantages and 
challenges in the current STI and cancer control strategies should be regularly evaluated 
and updated, to better design and implementation of adjusted STI and cancer control 
strategies. The current best practice guidelines on STI and cancer control should be applied 
according to the regional situation. TA joint approach with political, including social and 
economic, commitment is needed to reduce stigma across the nation. 
 
 Products, services and activities 
The industry 
Third, the results of this thesis should be interesting for the pharmaceutical and 
biotechnological industry, both Russian and global players. The high prevalence of 
bacterial STI, including Ct, among some populations requires the introduction of effective 
and not costly antibiotics to the market as well as proper control on antibacterial 
resistance. The high prevalence of STI, including HIV, among some populations, in 
particular among high-risk and/or stigmatized, could pave the way for the development 
and introduction of point-of-care diagnostic tests. In addition to the domination on the 
domestic market, Russian diagnostic companies could also consider to extend their 
diagnostic solutions, potentially through franchise networks, onto the markets of low-
income countries. The biobanks of STI samples could be established. Global 
biotechnological manufacturers could apply novel technologies in the areas and on 
clinical specimen previously not investigated. 
 
Policy makers 
Fourth, policy makers could consider to implement revised STI control and cancer 
prevention strategies, which would include the educational programmes on prevention 
and importance of early detection of STI across the nation, lack the stigma on sexual 
minorities, importance of collaboration and sharing knowledge, implementation of 
cervical screening and HPV vaccination programmes. This should also result in 
improvement of case reporting and surveillance systems, obtaining reliable 
epidemiological data in the country on Ct, HPV and other STI, including HIV, to better 
control of STI.  
 
Translation and innovation 
The results of this thesis could contribute to the translation of research into process, 
product, and eventually more research.  
 
Process  
The current findings on Ct prevalence in Russia give an opportunity for the development 
and introduction of Chlamydia screening programmes among high-risk populations in the 
 country. The results of this thesis inform healthcare policy makers regarding on which 
populations such programmes could apply and which diagnostic approaches could be 
used, including tests and anatomical sites to be sampled (Chapter 2).  
     An improved systematic and comprehensive surveillance and control system, obtained 
through a joint participation of all parties involved on the regional and federal levels, 
would be suitable to identify the real incidence of Ct and other STI infections, including 
HIV, potentially monitor diagnostic and treatment failures and collect data on 
microbiological characteristics of STI and the scale of antibacterial resistance. Improved 
knowledge about the distribution of these STI will move the public health agenda towards 
better STI and HIV prevention and treatment programmes that would result in developing 
and promoting educational campaigns, reducing stigma and approaching the populations 
of the great need across the nation. An improved subsequent control of STI will also save 
costs for the public health system, as it will reduce long-term complications, potentially 
decrease HIV transmission, and moreover decrease healthy life years lost by improving 
physical, psychological, and sexual health. On the global scale, understanding of reasons 
for global diversification of Ct strain types, obtained through collecting and sequencing 
Chlamydia-positive samples within screening and improved diagnostic programmes in 
Russia will improve knowledge on the natural history of Ct, decipher transmission 
patterns of the bacterium and, potentially, treatment failure (as described in Chapter 3).  
     The first national data on HPV prevalence in the anal canal among a male population 
that included MSW and MSM of a diverse HIV status (Chapters 7 and 8) should be 
extended with the studies among the general population, including different anatomical 
sites, to obtain the national data on HPV prevalence in men and women with anal and in 
women with cervical intraepithelial neoplasia, as a baseline for surveillance of the 
vaccination program. This will help to move the public health agenda towards organized 
HPV-based cervical cancer screening in women and gender-neutral HPV vaccination 
programmes as cost-effective, priority cancer prevention strategy.  
 
Products 
The thesis proposes several product decisions that could be of great interest for clinicians, 
public health specialists and policy makers in Russia and worldwide.   
First, the studies in the thesis stress the importance of establishment of national 
biobanking programmes. Clinical significance of diversity in Ct variants between Russia 
 and other geographic regions, observed abundance of HPV types detected in prostate 
secretion and anal specimens and their role in cancerogenesis, or further studies on the 
microbiome will request such large and geographically diverse collection of clinical 
samples. Second, the thesis invites the (local) industry to (further) develop and introduce 
accurate and rapid molecular point-of-care tests in the world of STI, in particular Ct and 
HIV. Third, more accurate (than based on the detection of HPV DNA) diagnostic 
approaches that could allow to distinguish between new or persistent HPV infection will 
have great health benefits compared to the classical diagnostic approach and can be 
implemented not only for HPV epidemiology and transmission studies but also in cancer 
prevention strategies.  
 
Research 
The thesis provides research leading to answers, but also leading to more questions.  
 
 Available data on the epidemiology of Ct and other STI, including HIV, in Russia 
remain limited. National reports on STI exist but the case reporting and STI 
surveillance system, including compulsory partner notification and tracing are 
needed to be improved. Little if any Ct studies have been performed among 
established high-risk populations (MSM, female sex workers, etc.). No studies on 
potentially present LGV infections among high-risk populations have been done. 
The diagnostics of Ct remain suboptimal in many places. More research is needed 
to estimate the real figures on epidemiology of Ct and other STI in Russia.  
 There are some geographic variations in Chlamydia strains between different 
geographic areas (e.g. between Russia and Europe, Europe and Americas). More 
additional research is needed to elucidate potentially existing selective pressure 
and/or adaptive diversification in different regions worldwide and the reasons 
behind that.  
 The access to antibiotics in Russia is regulated but self-medication practices are 
common due to the ongoing non-prescription access to antimicrobials and popular 
self-prescribing. As inadequate treatment may result in short and long term 
complications, more research is needed to estimate the scale of the problem. 
 Data on the prevalence of genital HPV infection in Russia is geographically narrow 
and remain limited with the cervix. The number of national studies on the 
 relationships between HPV and cancer is scarce. National studies on the 
relationships between HPV and anal cancer among high-risk populations are 
lacking. More research is needed to estimate the epidemiology of HPV in Russia, 
including among high-risk populations. 
 Studies among sexual minorities are limited and complicated due to social stigma. 
Implementation research especially focused on interventions for STI prevention 
and point-of-care approaches to disease diagnosis, including qualitative research 
on issues such as stigma, is needed.  
 There is no organized HPV vaccination programme in Russia. To launch 
educational campaigns for successful HPV vaccination programmes, research on 
how the population and professionals in the country would accept HPV vaccines 
would be recommended.  
 Many microorganisms are continuously threatening to infect the human urogenital 
tract (including prostate) and (also) anal canal, but their virulence is balanced by 
host-protective mechanisms. The further molecular and genomic studies are 
needed to elucidate whether transmitted STI or harbouring (non-)viral infections 
are involved in genital and anal carcinogenesis in both men and women, to analyse 
the potential protective and causative role of microbiome.  
 The presence of HPV DNA does not necessarily indicate the presence of infectious 
virus. It is also important to study whether HPVs detected in the anal canal in MSW 
by PCR-based technology are viable and have clinical consequences. Further 
studies might also explain transmission of HPV types among men and to their 
(sexual) partners, the tissue tropism and role of cutaneous HPVs in anal disorders. 
 Ongoing modelling and cost-effectiveness studies relevant to STI are narrow 
geographically but lacking in Russia. To better addressing STI prevention and 
treatment interventions, further studies should focus on these aspects.  
 
These key points above should be focus of further research, with the potential to provide 
clinical practice and public health specialists and policy makers with relevant data on the 
two most common bacterial and viral STI worldwide, to give further guidance towards 
better STI control and cancer prevention strategies.  
 
